Cambridge Innovation Capital

Type

Venture Capital

Status

Active

Location

Cambridge, United Kingdom

Total investments

86

Average round size

35M

Portfolio companies

42

Rounds per year

7.82

Lead investments

16

Follow on index

0.51

Exits

3

Stages of investment
SeedEarly Stage Venture
Areas of investment
BiotechnologySoftwareInformation TechnologyArtificial IntelligenceMachine LearningHealth CareGeneticsMedical DeviceMedicalTherapeutics

Summary

In 2013 was created Cambridge Innovation Capital, which is appeared as VC. The main office of represented VC is situated in the Cambridge. The company was established in Europe in United Kingdom.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Cambridge Innovation Capital, startups are often financed by Parkwalk Advisors, Cambridge Angels group, University of Cambridge Enterprise. The meaningful sponsors for the fund in investment in the same round are Amadeus Capital Partners, IQ Capital, Escala Capital. In the next rounds fund is usually obtained by Martlet, Innovate UK, Amadeus Capital Partners.

The fund has no exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom. Among the most popular portfolio startups of the fund, we may highlight Origami Energy, Gyroscope Therapeutics, Carrick Therapeutics. We can highlight the next thriving fund investment areas, such as Information Technology, Medical Device. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

We also calculated 10 valuable employees in our database.

This Cambridge Innovation Capital works on 25 percentage points less the average amount of lead investments comparing to the other organizations. The real fund results show that this VC is 24 percentage points more often commits exit comparing to other companies. The top amount of exits for fund were in 2019. The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2016. The fund is generally included in 7-12 deals every year. The typical startup value when the investment from Cambridge Innovation Capital is 100-500 millions dollars.

Show more

Investor highlights

Industry focus
Biotech/Life SciencesDeep TechMedtechRoboticsAI/Big Data
Stage focus
Series ASeed
Geo focus
United Kingdom, England, Cambridge

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
GBP 225000000
Fund raised date
2022-04-25

Analytics

Total investments
86
Lead investments
16
Exits
3
Rounds per year
7.82
Follow on index
0.51
Investments by industry
  • Biotechnology (32)
  • Health Care (29)
  • Software (21)
  • Therapeutics (18)
  • Artificial Intelligence (16)
  • Show 58 more
Investments by region
  • United Kingdom (76)
  • United States (6)
  • Ireland (2)
  • China (1)
Peak activity year
2016
Number of Unicorns
1
Number of Decacorns
1
Number of Minotaurs
2

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
8
Avg. valuation at time of investment
64M
Group Appearance index
0.84
Avg. company exit year
7
Strategy success index
0.40

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Phosphor AI 04 Jan 2024 Seed 2M Hong Kong, Hong Kong, China
Pretzel Therapeutics 12 Sep 2022 Biotechnology, Pharmaceutical, Therapeutics Early Stage Venture 72M United States, Massachusetts, Waltham

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.